Sky Harbour Group Corp current report, 29 November 2023

Sky Harbour Group Corporation Form 8-K Summary

Business Context and Reporting Period

Sky Harbour Group Corporation filed this Current Report on November 29, 2023, under Items 3.02, 7.01, and 9.01. The filing reports the second closing of a private investment in public equity financing and related warrant issuance.

Key Financial and Capitalization Matters

  • Sky Harbour issued 2,307,692 shares of Class A common stock and warrants to purchase 400,000 additional shares.
  • The additional financing generated aggregate gross proceeds of $15.0 million.
  • Including the initial closing on November 2, 2023, total financing under the securities purchase agreement was $57.81 million.
  • The warrants have an exercise price of $11.50 per share, are fully exercisable, and expire on January 25, 2027, subject to applicable adjustment provisions.
  • The filing does not provide updated revenue, profitability, cash flow, margins, debt, cash balance, liquidity, or use-of-proceeds amounts beyond the stated financing proceeds.

Material Changes and Terms

  • The securities were sold in unregistered transactions relying on Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D.
  • The purchase agreement limits the company’s use of net proceeds from the additional financing.
  • Investors are subject to customary standstill restrictions for 90 days after the second closing and a six-month lock-up beginning on the initial closing date.
  • Altai Capital Falcon LP, the lead investor, received participation rights in certain future equity and debt offerings through the 18-month anniversary of the initial closing date.
  • The agreement restricts extraordinary dividends if they could result in warrant exercises exceeding the number of shares issuable without NYSE American stockholder approval.

Outlook, Risks, and Unusual Items

The filing does not provide new operating guidance or financial outlook. Key considerations include dilution from the newly issued shares and potential future dilution from warrant exercises, restrictions on the use of financing proceeds, investor participation rights in future financings, and the unregistered status and resale limitations of the securities.

Investor Verification Points

  • Verify the company’s intended use of the $15.0 million of additional gross proceeds and the net proceeds after transaction expenses.
  • Assess the effect of the 2,307,692 newly issued shares and 400,000 warrants on current and fully diluted share counts.
  • Review the warrant adjustment provisions and the potential impact of the $11.50 exercise price.
  • Confirm compliance with the financing covenants, lock-up, standstill, dividend, and future financing participation provisions.
  • Review Exhibit 99.1 and subsequent filings for management commentary, operating results, liquidity updates, and financing-related developments.